CompuMed (CMPD) Stock Price

CompuMed Price

NYSE·CLOSED
6.26
​
Market closed

Revenue has compounded at 6.9% per year over the past 21 years to 7.55 M USD. Earnings per share have grown at 11.0% per year over the last 9 years. CompuMed's net margin stands at -0.9%, down from 16.9% several years earlier.

CompuMed stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CompuMed business model & stock analysis

CompuMed Inc., based in Los Angeles, US, provides enterprise telemedicine solutions specializing in telecardiology and teleradiology. The company offers cloud-based access to U.S. Board-Certified specialists for diagnosing cardiovascular diseases and osteoporosis, utilizing integrated medical devices such as GE MAC 1200 ECG equipment and GE Vscan ultrasound devices. Its network processes ECGs, echocardiograms, ultrasounds, and X-rays remotely, connecting point-of-care diagnostic data with specialists via a centralized call center.

Frequently asked questions about CompuMed

Converted at the current exchange rate, the CompuMed share trades at 5.57 EUR (6.26 USD).

The revenue cannot currently be calculated for CompuMed.

The profit cannot currently be calculated for CompuMed.

The P/E ratio cannot be calculated for CompuMed at the moment.

The P/S cannot be calculated for CompuMed currently.

The Eulerpool Quality Score for CompuMed is 2/10.

The ISIN of CompuMed is US2049145012. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of CompuMed is 883718. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of CompuMed is CMPD. The ticker symbol is used to trade CompuMed shares on the stock exchange.

Fair ValueTerminal
6.57 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
943,275.13 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
May 28, 1987
ISIN
US2049145012
Cusip
204914402
Sedol
2212159
Market capitalization
6.97 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
2.25
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-1.68 %
Last updated Oct 18, 2026, 9:42 PM

All fundamentals and in-depth analysis of CompuMed

Our stock analysis for CompuMed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CompuMed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.